Portable Ultrasound to Predict Heart Failure Readmission Risk

Sponsor

The Guthrie Clinic (Other)

Overall Status

Not yet recruiting

CT.gov ID

NCT05980533

Collaborator

(none)

Enrollment

Arm

Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

The purpose of this research is to use a handheld ultrasound to assess patients with congestive heart failure (CHF) to see if the ultrasound can help predict readmission to the hospital. The study will include patients who are admitted to the hospital for CHF. Participants will have two ultrasounds at hospital discharge and at a follow up visit.

Condition or Disease	Intervention/Treatment	Phase
Heart Failure Patient Readmission	Diagnostic Test: Ultrasound	N/A

Detailed Description

The purpose of this research is to see if a portable ultrasound can help predict readmission to the hospital for patients who are admitted to the hospital for CHF. The study will enroll patients who take part in Mobile Integrated Healthcare as part of their routine care. Participants will have two ultrasounds. The first ultrasound will be at hospital discharge.

Between seven to ten days after hospital discharge participants will be visited at their home in follow-up as the usual standard of care for Mobile Integrated Healthcare. At this visit participants will have a second ultrasound. Participants will be followed for one year for hospital readmission.

Study Design

Study Type:

Interventional

Anticipated Enrollment :

50 participants

Allocation:

N/A

Intervention Model:

Single Group Assignment

Masking:

None (Open Label)

Primary Purpose:

Diagnostic

Official Title:

Utility and Feasibility of Prehospital Portable Ultrasound to Predict Heart Failure Readmission Risk

Anticipated Study Start Date :

Aug 30, 2023

Anticipated Primary Completion Date :

Aug 30, 2024

Anticipated Study Completion Date :

Aug 30, 2025

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Ultrasound Ultrasound at hospital discharge and at follow up in 7-10 days	Diagnostic Test: Ultrasound Ultrasound at hospital discharge and at follow up at 7-10 days

Arm

Intervention/Treatment

Experimental: Ultrasound

Ultrasound at hospital discharge and at follow up in 7-10 days

Diagnostic Test: Ultrasound

Ultrasound at hospital discharge and at follow up at 7-10 days

Outcome Measures

Primary Outcome Measures

Hospital Readmission [30 days]
Hospital readmission within 30 days of discharge

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Primary admission diagnosis is listed as congestive heart failure, with an acute component of decompensation.
Age greater than 18 years.
Principal residence within the geographic reach of our MIH program.

Exclusion Criteria:

pregnant women

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

The Guthrie Clinic

Investigators

Principal Investigator: Zachary Dewar, The Guthrie Clinic

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

The Guthrie Clinic

ClinicalTrials.gov Identifier:

NCT05980533

Other Study ID Numbers:

2307-41

First Posted:

Aug 8, 2023

Last Update Posted:

Aug 8, 2023

Last Verified:

Jul 1, 2023

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by The Guthrie Clinic

Ultrasound

Additional relevant MeSH terms:

Heart Failure

Study Results

No Results Posted as of Aug 8, 2023